Etretinate therapy for papuloerythroderma

European Journal of Dermatology

Volumn 9, Issue 8, 1999, Pages 610-613

  Fujii, Kimio ^a   Kanno, Yuko ^a   Ohgo, Noriko ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Etretinate; Papuloerythroderma

Indexed keywords

ANTIHISTAMINIC AGENT; ETRETINATE; STEROID;

AGED; ARTICLE; CHEILITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ERYTHRODERMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PAPULAR SKIN DISEASE; PARONYCHIA; PATHOGENESIS; REMISSION; STEROID THERAPY;

AGED; AGED, 80 AND OVER; ETRETINATE; HUMANS; KERATOLYTIC AGENTS; MALE; SKIN DISEASES, PAPULOSQUAMOUS;

EID: 0033458761     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1. Ofuji S, Furukawa F, Miyachi Y, Ohno S. Papuloerythroderma. Dermatologica 1984; 169: 125-30.
2. 2. Grob JJ, Collet-Villette AM, Horchowski N, Dufaud M, Prin L, Bonerandi JJ. Ofuji papuloerythroderma. Report of a case with T cell skin lymphoma and discussion of the nature of this disease. J Am Acad Dermatol 1989; 20: 927-31.
3. 3. Harris DWS, Spencer MJ, Tidman MJ. Papuloerythroderma-clinical and ultrastructural features. Clin Exp Dermatol 1990; 15: 105-6.
4. 4. Nazzari G, Crovato F, Nigro A. Papuloerythroderma (Ofuji): two additional cases and review of the literature. J Am Acad Dermatol 1992; 26: 499-501.
5. 5. Wakeel RA, Keefe M, Chapman RS. Papuloerythroderma: another case of a new disease. Arch Dermatol 1991; 127: 96-8.
6. 6. Boden G, Degreef H, van den Oord JJ. Papuloerythroderma: report of a European case. Dermatology 1993; 186: 193-6.
7. 7. Dwyer CM, Chapman RS, Smith GD. Papuloerythroderma and cutaneous T cell lymphoma. Dermatology 1994; 188: 326-8.
8. 8. Farthing CF, Staughton RCD, Harper Jl, Rowland Payne CME, Copeman PWM. Papuloerythroderma - a further case with the "deck chair sign". Dermatologica 1986; 172: 65-6.
9. 9. Bettoli V, Mantovani L, Altieri E, Strumia R. Ofuji papuloerythroderma: report of a European case. Dermatology 1993; 186: 187-9.
10. 10. Dubertret L, Lebeton C, Touraine R. Inhibition of neutrophil migration by etretinate and its main metabolite. Br J Dermatol 1982; 107: 681-5.
11. 4 production. Prostaglandins 1990; 39: 569-77.
12. 12. Dennert G, Lotan R. Effects of retinoic acid on the immune system: stimulation of T-killer cell induction. Eur J Immunol 1978; 8: 23-9.
13. 13. Cloudy AL, Rouchouse B, Boucheron S, Lepetit JC. Treatment of cutaneous lymphoma with etretinate. Br J Dermatol 1983; 109: 49-56.